Written by: Kristina Lybecker | Published:
Merck’s once-daily, single-tablet combination of grazoprevir and elbasvir proved effective in treating even the sickest hepatitis C patients, without negative side effects.
Written by: Emily Williams | Published:
Throughout the next few months, Ward Health will be profiling Canadian Leaders in Global Health.
Written by: Kristina Lybecker | Published:
Sovaldi is a breakthrough drug for hepatitis C that has been shown to cure more than 90 percent of patients in just twelve weeks, adding value to the healthcare system and transforming lives. It...
Written by: Ward Health | Published:
On September 9th, 2013, a multi-stakeholder group of about 50 participants concerned about neglected tropical disease (NTDs) in India assembled in New Delhi for a day-long workshop. Their...